Viúdez, A <br/><br/>
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry.  [electronic resource] 

 -  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico  May 2020 
 - 734-750 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1699-3055 
<br/><br/><label>Standard No.: </label>10.1007/s12094-019-02183-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Decision-Making<br/>Female<br/>Humans<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Platinum--administration & dosage<br/>Progression-Free Survival<br/>Pyrimidines--administration & dosage<br/>Registries<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Time Factors<br/>Young Adult